Abstract
The CyPass Micro-Stent (Transcend Medical, Menlo Park, CA) is a fenestrated device that is implanted in the supraciliary space to provide a permanent conduit for uveoscleral outflow of aqueous humor from the anterior chamber in patients with glaucoma. Implantation is achieved with a blebless, minimally invasive clear cornea incision that spares the conjunctiva and the sclera and which can be performed with or without the use of surgical intraoperative gonioscopy. By exploiting the negative pressure gradient between the suprachoroidal space and the anterior chamber, the successfully positioned micro-stent facilitates aqueous outflow and thereby lowers IOP and reduces the patient’s need for IOP-lowering medications. Clinical experience to date indicates a good safety profile and prolonged efficacy for the micro-stent when used either as a stand-alone treatment for open-angle glaucoma or in combination with phacoemulsification surgery in glaucomatous patients undergoing cataract removal.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Nguyen QH, Ahmed II, Craven ER, Anton-Lopez A, Grisante S, Ianchuler T. Biocompatibility of a polymide suprachoroidal microstent (Cypass) for intra-ocular pressure lowering in glaucoma: 6 months rabbit animal model. Association for Research in Vision and Ophthalmology annual meeting, Ft Lauderdale, FL, 6–9 may 2012.
Guguchkova P, Samsonova B, Topov A, Ianchulev T. Conio-free minimally invasive glaucoma suprachoroidal microstent implantation. American Society of cataract and Refractive surgery annual meeting, San Francisco, CA, 19–23 Apr 2012.
Emi K, Pederson JE, Toris CB. Hydrostatic pressure of the suprachoroidal space. Invest Ophthalmol Vis Sci. 1989;30(2):233–8.
Razeghinejad MR, Spaeth GL. A history of the surgical management of glaucoma. Optom Vis Sci. 2011;88(1):E39–47.
Toris CB. Pharmacotherapies for glaucoma. Curr Mol Med. 2010;10(9):824–40.
Ianchulev T, Ahmed K, Hoeh HR, Rau M. Minimally invasive ab interno suprachoroidal device (CyPass) for IOP control in open-angle glaucoma. American Academy of Ophthalmology annual meeting, Chicago, 18–19 Oct 2010.
Craven ER, Khatana A, Hoeh H, Rau M, Ianchuler T. Safety of minimally invasive, abinterno suprachoroidal micro-stent for IOP reduction used in combination with phaco cataract surgery. American academy of Ophthalmology annual meeting, Orlando, FL, 22–25 Oct 2011.
Garcia-Feijoo J, Rau M, Ahmed I, Anton A, Grabner G, Ianchulev T. Safety and efficacy of CyPass Micro-Stent as a stand-alone treatment for open-angle glaucoma: worldwide clinical experience. European Society of Cataract and Refractive Surgeons annual meeting, Milan, 8–12 Sept 2012.
Hoeh H, Rau M, Reitshamer H, Rapisarda A, Ianchulev T, editors. Clinical outcomes of combined cataract surgery and implantation of the CyPass Micro-Stent for the treatment of open-angle glaucoma. In: European Society of Cataract and Refractive Surgeons, Milan, 10 Sept 2012.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ianchulev, T. (2014). The CyPass Suprachoroidal Micro-Stent. In: Samples, J.R., Ahmed, I.I.K. (eds) Surgical Innovations in Glaucoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8348-9_21
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8348-9_21
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8347-2
Online ISBN: 978-1-4614-8348-9
eBook Packages: MedicineMedicine (R0)